Afternoons With Rob Breakenridge
Feds decision to cover expensive drug for rare disorder doesn't go far enough
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:10:32
- More information
Informações:
Synopsis
The federal gov't has approved covering the costs for expensive drug Spinraza for patients with type 1 spinal muscular atrophy, but patients with type 2 and type 3 are still having to foot the bill for their treatment. And the bill is steep. Kira Leavitt-Palmer's son Evan is type 2. Learn more about your ad choices. Visit megaphone.fm/adchoices
